FRIEDRICHSDORF

DGAP-News: Dermapharm Holding SE - subsidiary axicorp GmbH breaks ground for a new building near Frankfurt/Main

Retrieved on: 
Wednesday, September 30, 2020

Grnwald, September 30, 2020 - Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas, is beginning with construction of a state-of-the-art production, storage and administration building at the Friedrichsdorf site of its subsidiary axicorp GmbH.

Key Points: 
  • Grnwald, September 30, 2020 - Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas, is beginning with construction of a state-of-the-art production, storage and administration building at the Friedrichsdorf site of its subsidiary axicorp GmbH.
  • The new building with approximately 10,000 m of space will replace the previously rented floor space on 17,488 m of commercial property.
  • In addition to the associated optimization of the cost structure, Dermapharm intends to achieve a significant improvement in processes with the new building.
  • Founded in 1991, the company is based in Grnwald near Munich and has its main manufacturing facility in Brehna near Leipzig.